Side-by-side comparison of AI visibility scores, market position, and capabilities
US YC W20 AI Medicare guidance platform launched Vox in Aug 2024; conversational AI for 67M Medicare beneficiaries navigating plan selection and enrollment competing with GoHealth for 24/7 AI-first Medicare Advantage and Supplement comparison.
Medicare Vox (formerly Fair Square Medicare) is a United States-based AI-powered Medicare insurance guidance platform — backed by Y Combinator (W20) — providing Medicare beneficiaries and their families with 24/7 conversational AI-powered assistance for Medicare plan selection, enrollment navigation, and claims guidance through its Vox platform launched in August 2024. Originally founded in 2019 as Fair Square Medicare — a licensed insurance agency helping seniors compare and enroll in Medicare Advantage and Medicare Supplement (Medigap) plans — the company rebranded and launched the Vox AI platform to scale Medicare beneficiary support beyond the capacity of human insurance agents, addressing the complex decision-making that Medicare's 67 million enrollees face when choosing among hundreds of available plans during the annual Open Enrollment Period.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.